Ayşe İpek AKYÜZ ÜNSAL, Özge KEY, Duygu GÜLER, Sinan BEKMEZ, Mehtap SAGUS, Abdullah Barış AKCAN, İmran Kurt ÖMÜRLÜ, Ayşe ANIK, Sema ORUÇ DÜNDAR, Münevver TÜRKMEN

Retinopathy of prematurity risk factors: Does human milk prevent retinopathy of prematurity?

The aim of this study was to investigate the risk factors for Retinopathy ofPrematurity (ROP) development and the potential effect of human breast milkamong these factors. For this purpose, infants admitted to a tertiary referralclinic for ROP screening and treatment between April 2013 and May 2015,were included in this retrospective study. The demographic data, accompanyingdiseases, previous surgery, type of feeding and duration of human breast milkintake were recorded. According to the ROP screening examination results,infants were divided into two groups as those with ROP (infants at any stageof ROP) and those without ROP. Relationship between the risk factors and ROPwere evaluated. The comparison of 221 infants without ROP and 99 infantswith ROP; revealed that gestational age at birth, birth weight, mechanicalventilation support, bronchopulmonary and cardiac diseases, hydrocephaly,any previous surgery, infections, steroid treatment percentages were high andhuman breast milk intake percentage was low among infants with ROP. Meanbreast feeding time for infants with ROP (3.81 ± 2.33 month) was shorterthan the infants without ROP (5.51 ± 1.43 month) (p

PDF

___

1. Gilbert C. Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008; 84: 77-82.

2. Fortes Filho JB, Eckert GU, Procianoy L, Barros CK, Procianoy RS. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye (Lond) 2009; 23: 25-30.

3. Sarikabadayi YU, Aydemir O, Ozen ZT, et al. Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: Frequency and risk factors. Ophthalmic Epidemiol 2011; 18: 269-274.

4. Alpay A, Uğurbaş SH. Incidence and risk factors for retinopathy of prematurity in the West Black Sea region, Turkey. Turk J Pediatr 2012; 54: 113-118.

5. Yau GSK, Lee JWY, Tam VTY, Liu CCL, Chu BCY, Yuen CYF. Incidence and risk factors for retinopathy of prematurity in extreme low birth weight Chinese infants. Int Ophthalmol 2015; 35: 365-373.

6. Park SH, Yum HR, Kim S, Lee YC. Retinopathy of prematurity in Korean infants with birthweight greater than 1500 g. Br J Ophthalmol 2016; 100: 834-838.

7. Bas AY, Koc E, Dilmen U; ROP Neonatal Study Group. Incidence and severity of retinopathy of prematurity in Turkey. Br J Ophthalmol 2015; 99: 1311-1314.

8. Good WV, Hardy RJ, Dobson V, et al; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 2010; 128: 663-671.

9. VanderVeen DK, Bremer DL, Fellows RR, et al; Early Treatment for Retinopathy of Prematurity Cooperative Group. Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. J AAPOS 2011; 15: 536-540.

10. Wu WC, Lin RI, Shih CP, et al. Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity. Ophthalmology 2012; 119: 1907-1916.

11. Fielder A, Blencowe H, O’Connor A, Gilbert C. Impact of retinopathy of prematurity on ocular structures and visual functions. Arch Dis Child Fetal Neonatal Ed 2015; 100: F179-F184.

12. Vijayalakshmi P, Kara T, Gilbert C. Ocular morbidity associated with retinopathy of prematurity in treated and untreated eyes: A review of the literature and data from a tertiary eye-care center in southern India. Indian Pediatr 2016; 53(Suppl 2): S137-S145.

13. Akkoyun I, Oto S, Yilmaz G, et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006; 10: 449-453.

14. Thomas K, Shah PS, Canning R, Harrison A, Lee SK, Dow KE. Retinopathy of prematurity: Risk factors and variability in Canadian neonatal intensive care units. J Neonatal Perinatal Med 2015; 8: 207-214.

15. Slidsborg C, Jensen A, Forman JL, et al. Neonatal Risk Factors for Treatment-Demanding Retinopathy of Prematurity: A Danish National Study. Ophthalmology 2016; 123: 796-803.

16. Alajbegovic-Halimic J, Zvizdic D, Alimanovic-Halilovic E, Dodik I, Duvnjak S. Risk factors for retinopathy of prematurity in premature born children. Med Arhc 2015; 69: 409-413.

17. Jacob MK, Sawardekar KP, Ayoub HG, Busaidi IA. Validation of the existing modified screening criteria for detection of all cases of Retinopathy of Prematurity in preterm babies – 11 year study from a governorate referral hospital in Oman. Saudi J Ophthalmol 2016; 30: 3-8.

18. Kumar P, Sankar MJ, Deorari A, et al. Risk factors for severe retinopathy of prematurity in preterm low birth weight neonates. Indian J Pediatr 2011; 78: 812-816.

19. Hylander MA, Strobino DM, Pezzullo JC, Dhanireddy R. Association of human milk feedings with a reduction in retinopathy of prematurity among very low birthweight infants. J Perinatol 2001; 21: 356-362.

20. Heller CD, O’Shea M, Yao Q, et al; NICHD Neonatal Research Network. Human milk intake and retinopathy of prematurity in extremely low birth weight infants. Pediatrics 2007; 120: 1-9.

21. Okamoto T, Shirai M, Kokubo M, et al. Human milk reduces the risk of retinal detachment in extremely low-birthweight infants. Pediatr Int 2007; 49: 894-897.

22. Kao JS, Dawson JD, Murray JC, et al. Possible roles of bilirubin and breast milk in protection against retinopathy of prematurity. Acta Paediatr 2011; 100: 347-351.

23. Manzoni P, Stolfi I, Pedicino R, et al; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology. Human milk feeding prevents retinopathy of prematurity (ROP) in preterm VLBW neonates. Early Hum Dev 2013; 89(Suppl 1): S64-S68.

24. Zhou J, Shukla VV, John D, Chen C. Human Milk Feeding as a Protective Factor for Retinopathy of Prematurity: A Meta-analysis. Pediatrics 2015; 136: e1576-e1586.

25. Bharwani SK, Green BF, Pezzullo JC, Bharwani SS, Dhanireddy R. Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: A significant update. J Perinatol 2016; 36: 913-920.

26. Gregory KE, Walker WA. Immunologic factors in human milk and disease prevention in the preterm infant. Curr Pediatr Rep 2013; 1: 10.1007/s40124-013-0028-2.

27. Ballard O, Morrow AL. Human milk composition: Nutrients and bioactive factors. Pediatr Clin North Am 2013; 60: 49-74.

28. Kon IY, Shilina NM, Gmoshinskaya MV, Ivanushkina TA. The study of breast milk IGF-1, leptin, ghrelin and adiponectin levels as possible reasons of high weight gain in breast-fed infants. Ann Nutr Metab 2014; 65: 317-323.

29. The International Classification of Retinopathy of Prematurity revisited. An International Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 2005; 123: 991-999.

30. Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial. Early Treatment for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 2003; 121: 1684-1696.

31. Koç E, Baş AY, Özdek Ş, Ovalı F, Başmak H; TOD - ROP Komisyonu, TND - ROP Çalışma Grubu. Türkiye Prematüre Retinopatisi Rehberi 2016.

32. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet 2013; 382: 1445-1457.

33. Caufriez A, Frankenne F, Englert Y, et al. Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol 1990; 258(6 Pt 1): E1014-E1019.

34. Langford K, Nicolaides K, Miell JP. Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Human Reprod 1998; 13: 1389-1393.

35. Engström E, Niklasson A, Wikland KA, Ewald U, Hellström A. The role of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res 2005; 57: 605-610.

36. Stahl A, Chen J, Sapieha P, et al. Postnatal weight gain modifies severity and functional outcome of oxygeninduced proliferative retinopathy. Am J Pathol 2010; 177: 2715-2723.

37. Hansen-Pupp I, Löfqvist C, Polberger S, et al. Influence of insulin-like growth factor I and nutrition during phases of postnatal growth in very preterm infants. Pediatr Res 2011; 69(5 Pt 1): 448-453.

38. Vanhaesebrouck S, Daniëls H, Moons L, Vanhole C, Carmeliet P, De Zegher F. Oxygen-induced retinopathy in mice: Amplification by neonatal IGF-I deficit and attenuation by IGF-I administration. Pediatr Res 2009; 65: 307-310.

39. Hellström A, Engström E, Hard AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003; 112: 1016-1020.

40. Hellstrom A, Perruzzi C, Ju M, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001; 98: 5804-5808.

41. Matsubara M, Saito Y, Nakanishi-Ueda T, et al. Influence of the difference of breastfeeding volume on a rat model of oxygen-induced retinopathy. J Clin Biochem Nutr 2014; 55: 129-134.